Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line.

Voronina EV, Seregin YA, Litvinova NA, Shvets VI, Shukurov RR.

Springerplus. 2016 Sep 15;5(1):1584. doi: 10.1186/s40064-016-3213-2. eCollection 2016.

2.

PDCD1 PD-1.3 polymorphism and allergic bronchial asthma in Russian and Buryat patients.

Dmitrieva-Zdorova EV, Gabaeva MV, Seregin YA, Bodoev NV, Voronko OE.

J Asthma. 2017 Jan 2;54(1):46-52. doi: 10.1080/02770903.2016.1196366. Epub 2016 Jun 10.

PMID:
27286421
3.

RAGE expression in the human peritoneal membrane.

Kihm LP, Wibisono D, Müller-Krebs S, Pfisterer F, Morath C, Gross ML, Morcos M, Seregin Y, Bierhaus A, Nawroth PP, Zeier M, Schwenger V.

Nephrol Dial Transplant. 2008 Oct;23(10):3302-6. doi: 10.1093/ndt/gfn272. Epub 2008 May 13.

PMID:
18477569
4.

Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling.

Humpert PM, Djuric Z, Zeuge U, Oikonomou D, Seregin Y, Laine K, Eckstein V, Nawroth PP, Bierhaus A.

Mol Med. 2008 May-Jun;14(5-6):301-8. doi: 10.2119/2007-00052.Humpert.

5.

Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.

Schwenger V, Morath C, Salava A, Amann K, Seregin Y, Deppisch R, Ritz E, Bierhaus A, Nawroth PP, Zeier M.

J Am Soc Nephrol. 2006 Jan;17(1):199-207. Epub 2005 Nov 30.

Supplemental Content

Loading ...
Support Center